Fig. 1
From: CPA4 overexpression correlates with poor prognosis and tumor progression in endometrial cancer
Differential expression of CPA4 in endometrial carcinoma. A Analysis of CPA4 differential expression in unpaired samples. B Analysis of CPA4 differential expression in paired samples. C Analysis of CPA4 differential expression using data from data set GSE17025. D ROC curve for CPA4 as a biomarker